Idris Bahce
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab (NCT06908070) | Idris Bahce | 2024-12-17 |
Track Idris Bahce automatically
Every clearance here is in the API, with alerts when new ones post.